Modern Economy

Vol.5 No.5(2014), Paper ID 46067, 7 pages

DOI:10.4236/me.2014.55047

 

Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines—Part II

 

Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Maria Krasteva Bozhkova, Guenka Petrova

 

Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria
Faculty of Public Health, Medical University of Sofia, Sofia, Bulgaria
“Alexandrovska” Hospital, Medical University of Sofia, Sofia, Bulgaria
Medicine College, Medical University of Plovdiv, Plovdiv, Bulgaria
Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria

 

Copyright © 2014 Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Maria Krasteva Bozhkova, Guenka Petrova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Zlatareva, A. , Tachkov, K. , Stoicheva, M. , Georgieva, S. , Bozhkova, M. and Petrova, G. (2014) Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines—Part II. Modern Economy, 5, 499-505. doi: 10.4236/me.2014.55047.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.